[HTML][HTML] Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
Introduction Integrating interaction data with biological knowledge can be a critical approach
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer.
M Kori, B Turanli, K Arga - Frontiers in oncology, 2023 - avesis.marmara.edu.tr
IntroductionIntegrating interaction data with biological knowledge can be a critical approach
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
[PDF][PDF] Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, KY Arga - 2023 - scienceopen.com
Methods: Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …
[PDF][PDF] Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, KY Arga - 2023 - academia.edu
Methods: Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …
[HTML][HTML] Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, KY Arga - Frontiers in Oncology, 2023 - ncbi.nlm.nih.gov
Methods Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, KY Arga - Frontiers in oncology, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Integrating interaction data with biological knowledge can be a critical approach
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
for drug development or drug repurposing. In this context, host-pathogen-protein-protein …
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, K Arga - Frontiers in Oncology, 2023 - europepmc.org
Methods Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …
[PDF][PDF] Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
M Kori, B Turanli, KY Arga - 2023 - openaccess.marmara.edu.tr
Methods: Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer.
M Kori, B Turanli, KY Arga - Frontiers in Oncology, 2023 - europepmc.org
Methods Accordingly, in this study, we emphasize the potential of host proteins as drug
targets and identify promising host protein candidates for cervical cancer by considering …
targets and identify promising host protein candidates for cervical cancer by considering …